# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Extrahepatic bile duct cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 58 results.
Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer
Status: Recruiting
Last Changed: Sep 20, 2018
First Received: Sep 20, 2018
Disease(s): Nonresectable Bile Duct Cancer
Intervention(s): Ablation Therapy
Locations: Institut Paoli-Calmettes, Marseille, France
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Oct 29, 2015
Disease(s): Bile Duct Cancer
Intervention(s): GEMCIS, mFolfirinox
Locations: Chu Picardie, Amiens, France
Ico Paul Papin, Angers, France
CH Victor Dupouy, Argenteuil, France
CH de la Côte Basque, Bayonne, France
CHRU Besançon, Besançon, France
... and 38 other locations.
Phase II Study of HMPL-453 Tartrate in Patients With Advanced Intrahepatic Cholangiocarcinoma With FGFR2 Fusion
Status: Not yet recruiting
Last Changed: Jun 16, 2020
First Received: Apr 20, 2020
Disease(s): Advanced Bile Duct Cancer
Intervention(s): HMPL-453
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
Status: Recruiting
Last Changed: Oct 09, 2020
First Received: Sep 23, 2019
Disease(s): Cholangiocarcinoma
Intervention(s): Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemotherapy
Locations: City of Hope National Medical Center, Duarte, California, United States
Emory University Hospital, 1365C Clifton Road NE, Atlanta, Georgia, United States
University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, Illinois, United States
University of Louisville, Louisville, Kentucky, United States
The Mayo Clinic Hospital - Saint Mary's Campus, 1216 Second Street Southwest, Rochester, Minnesota, United States
... and 41 other locations.
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Status: Recruiting
Last Changed: Sep 29, 2020
First Received: Dec 26, 2016
Disease(s): Cholangiocarcinoma, Tumor, Klatskin Tumor
Intervention(s): Temoporfin
Locations: Endoscopy Centre, Prince of Wales Hospital, Shatin, N.t., Hong Kong
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
Status: Recruiting
Last Changed: Mar 19, 2020
First Received: Sep 03, 2019
Disease(s): Cholangiocarcinoma, Bile Duct Cancer
Intervention(s): Trifluridine/Tipiracil
Locations: Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Feb 27, 2018
Disease(s): Pancreatic Cancer or Distal CBD Cancer
Intervention(s): Des (volatile anesthetic-desflurane), TIVA (Total intravenous anesthesia with propofol and remifentanil)
Locations: Department of Anesthesiology and Pain Medicine Anesthesia and Pain Research Institute Yonsei University College of Medicine, Seoul, Korea, Republic of
DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer
Status: Recruiting
Last Changed: Jun 29, 2020
First Received: Mar 06, 2020
Disease(s): Bile Duct Cancer, Chemotherapy Effect
Intervention(s): AZD6738, Durvalumab, Olaparib
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
AZD6738 Plus Durvalumab in Biliary Tract Cancer
Status: Recruiting
Last Changed: Jun 29, 2020
First Received: Mar 06, 2020
Disease(s): Bile Duct Cancer, Chemotherapy Effect
Intervention(s): AZD6738, Durvalumab
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Status: Recruiting
Last Changed: Sep 28, 2020
First Received: Mar 22, 2017
Disease(s): Bile Duct Cancer, Intrahepatic Cholangiocarcinoma
Intervention(s): Melphalan/HDS, Cisplatin and Gemcitabine
Locations: Duke Health, Durham, North Carolina, United States
Ohio State University/Teaching Hospital, Columbus, Ohio, United States
West Cancer Center, Memphis, Tennessee, United States